Lupin Pharmaceuticals Inc. recalls Cefdinir for Oral Suspension USP, 250 mg/5mL, packaged in 60 mL bottles, Rx only, Manufactured for: Lupin
Lupin Pharmaceuticals recalls Cefdinir oral suspension (250mg/5mL) due to potential superpotent drug levels. This prescription medication was manufactured in India and distributed in the US. Consumers should contact Lupin for details.
Recall notice
Superpotent Drug: Out-of-specification (OOS) result observed in an assay test of retention samples.
Contact the company & request your remedy
What happened, in plain English
Lupin Pharmaceuticals is recalling a specific prescription Cefdinir oral suspension product because lab tests found it contained higher-than-normal drug levels. This could lead to an overdose if taken as directed. The product is only available with a prescription. Read more at govinfonow.com/recall/36967-lupin-recalls-cefdinir-oral-suspension-superpotent-drug-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/36967-lupin-recalls-cefdinir-oral-suspension-superpotent-drug-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-1406-2020
Cite this page
“Lupin recalls Cefdinir oral suspension: Superpotent drug risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/36967-lupin-recalls-cefdinir-oral-suspension-superpotent-drug-risk. Based on FDA recall #D-1406-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1406-2020%22&limit=1).
Why it’s dangerous
The lab tests showed the medication contained higher-than-normal drug levels. This could cause an overdose if taken as directed, but the product is only available with a prescription.
Who’s affected
Prescription patients who have the specific Cefdinir oral suspension (250mg/5mL) in 60mL bottles with NDC 68180-723-20. Those who have taken the product without a prescription are not affected.
How to tell if you have this one
Check for the product name 'Cefdinir for Oral Suspension USP', 250 mg/5mL, in 60 mL bottles. The NDC code is 68180-723-20. This product is prescription-only and manufactured by Lupin.
- Brand
Lupin- Category
Drug
What to do — step by step
Check Product Details
Look for the NDC code 68180-723-20 on the label of the Cefdinir oral suspension bottle.
Questions people ask
Is this product safe to use?
The recall is due to lab tests showing higher-than-normal drug levels, which could cause an overdose. This product is only available with a prescription.
What should I do if I have this product?
The recall does not specify a remedy, so contact Lupin Pharmaceuticals for instructions.
Is this product available over the counter?
No, this product is prescription-only and requires a doctor's order.
Contact Lupin
We’ve drafted a message you can send Lupin to request your refund or repair — edit it as you like.
Subject: Recall D-1406-2020 — Lupin Lupin Hello, I own a Lupin that is covered by recall D-1406-2020 from Lupin. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1406-2020 (July 2, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1406-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.